Mannheimia haemolytica is considered the major bacterial agent of the multifactorial bovine respiratory disease (BRD) complex, which results in a loss of over three billion U.S. dollars per year for the global cattle industry. Antimicrobial agents are commonly used to treat cattle that suffer from BRD. During recent years, a growing number of isolates showed resistance to one or more antimicrobial agents. Integrative and conjugative elements (ICEs), like the recently described ICEPmu11,2, may play a role as reservoirs for and distributers of antimicrobial resistance genes in Pasteurellaceae.
The M. haemolytica strain 42548 was subjected to whole genome sequencing3, followed by sequence analysis and comparative genomics.
One ICE was identified in M. haemolytica strain 42548 and designated ICEMh1. The ICEMh1 has a size of 92345 bp and harbours 107 open reading frames. ICEMh1 integrates into a tRNALeu in the chromosome. Additionally, it is able to transfer to P. multocida by conjugation. PCR assays confirmed the presence of the ICEMh1-associated resistance genes in the recipient strains. Within two resistance regions, approximately 7.4 kp and 3.3 kb in size, ICEMh1 harbours five resistance genes, which confer resistance towards streptomycin (strA and strB), kanamycin/neomycin (aphA1), tetracycline [tetR-tet(H)] and sulphonamides (sul2).
ICEMh1 is closely related to the ICEPmu1 and seems to have evolved from a common predecessor. A region of ICEMh1 that is not present in ICEPmu1, can be found in putative ICE regions of other M. haemolytica genomes, suggesting a recombination event of two ICEs. These findings support the observation that ICEs can easily spread, even across genus borders, allowing for the acquisition of multidrug-resistant profiles via a single horizontal gene transfer event. This poses a threat to therapeutic antimicrobial strategies in all fields, not only for the treatment of BRD.